참고문헌 (20)

1. Nanomedicine Y Chen 5 316 2009 10.1016/j.nano.2008.12.005 Chen Y, Lin X, Park H, Greever R (2009) Study of artemisinin nanocapsules as anticancer drug delivery system. Nanomedicine 5:316-322 

   상세보기

2. Biochem Pharmacol T Efferth 68 3 2004 10.1016/j.bcp.2004.03.003 Efferth T, Oesch F (2004) Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines. Biochem Pharmacol 68:3-10 

   상세보기

3. Int J Pharm J-Y Fang 219 61 2001 10.1016/S0378-5173(01)00627-5 Fang J-Y, Hong C-T, Chiu W-T, Wang Y-Y (2001) Effect of liposomes and niosomes on skin permeation of Enoxacin. Int J Pharm 219:61-72 

   상세보기

4. J Pharm Pharmacol A Fathi Azarbayjani 62 770 2010 10.1211/jpp.62.06.0014 Fathi Azarbayjani A, Lin H, Yap CW, Chan YW, Chan SY (2010) Surface tension and wettability in transdermal delivery: a study on the in-vitro permeation of haloperidol with cyclodextrin across human epidermis. J Pharm Pharmacol 62:770-778 

   상세보기

5. Biopharm Drug Dispos A Fathi Azarbayjani 32 380 2011 10.1002/bdd.766 Fathi Azarbayjani A, Khu JV, Chan YW, Chan SY (2011) Development and characterization of skin permeation retardants and enhancers: a comparative study of Levothyroxine-loaded PNIPAM, PLA, PLGA and EC microparticles. Biopharm Drug Dispos 32:380-388 

   상세보기

6. Sci Pharm A Fathi-Azarbayjani 81 4 1141 2013 10.3797/scipharm.1306-05 Fathi-Azarbayjani A, Tan PL, Chan YY, Chan SY (2013) Ascorbic acid for the safe use of a sunscreen agent: accumulation of nano zinc oxide and titanium dioxide on the skin. Sci Pharm 81(4):1141-1150 

   상세보기

7. Adv Pharm Bull A Fathi-Azarbayjani 5 1 25 2015 Fathi-Azarbayjani A, Ng KX, Chan YW, Chan SY (2015) Lipid vesicles for the skin delivery of diclofenac: cerosomes vs. other lipid suspensions. Adv Pharm Bull 5(1): 25-33 

   상세보기

8. Int J Pharm N Ibrahim 495 671 2015 10.1016/j.ijpharm.2015.09.020 Ibrahim N, Ibrahim H, Sabater AM, Mazier D, Valentin A, Nepveu F (2015) Artemisinin nanoformulation suitable for intravenous injection: preparation, characterization and antimalarial activities. Int J Pharm 495:671-679 

   상세보기

9. J Mol Liq MO Iwunze 111 161 2004 10.1016/j.molliq.2003.12.013 Iwunze MO (2004) Binding and distribution characteristics of curcumin solubilized in CTAB micelle. J Mol Liq 111:161-165 

   상세보기

10. Colloids Surf B Y Jing 2016 10.1016/j.colsurfb.2016.06.041 Jing Y, Danielsson A, Dobšíček Trefná H, Persson M, Svedhem S (2016) Asymmetric cationic liposomes designed for heat-activated association with cells. Colloids Surf B. doi: 10.1016/j.colsurfb.2016.06.041 

    상세보기

11. Eur J Pharm Sci MI Khan 95 88 2016 10.1016/j.ejps.2016.09.002 Khan MI, Madni A, Peltonen L (2016) Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur J Pharm Sci 95:88-95 

    상세보기

12. Expert Opin Ther Targets H Lai 9 995 2005 10.1517/14728222.9.5.995 Lai H, Sasaki T, Singh NP (2005) Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds. Expert Opin Ther Targets 9:995-1007 

    상세보기

13. Clin Pharmacokinet V Navaratnam 39 4 255 2000 10.2165/00003088-200039040-00002 Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q, Olliaro P (2000) Pharmacokinetics of artemisinin-type compounds. Clin Pharmacokinet 39(4):255-270 

    상세보기

14. Chem Phys Lipids P Palozza 139 32 2006 10.1016/j.chemphyslip.2005.09.004 Palozza P, Muzzalupo R, Trombino S, Valdannini A, Picci N (2006) Solubilization and stabilization of β-carotene in niosomes: delivery to cultured cells. Chem Phys Lipids 139:32-42 

    상세보기

15. J Control Release G Pasut 199 106 2015 10.1016/j.jconrel.2014.12.008 Pasut G, Paolino D, Celia C, Mero A, Joseph AS, Wolfram J, Cosco D, Schiavon O, Shen H, Fresta M (2015) Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. J Control Release 199:106-113 

    상세보기

16. Pharmacist SA Payghan 3 33 2008 Payghan SA, Bhat M (2008) Albumin microspheres containing artemisinin. Pharmacist 3:33-36 

17. Int J Pharm Y Shahzad 457 197 2013 10.1016/j.ijpharm.2013.09.027 Shahzad Y, Sohail S, Arshad MS, Hussain T, Shah SNH (2013) Development of solid dispersions of artemisinin for transdermal delivery. Int J Pharm 457:197-205 

    상세보기

18. Int J Pharm DS Shaker 493 285 2015 10.1016/j.ijpharm.2015.07.041 Shaker DS, Shaker MA, Hanafy MS (2015) Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes. Int J Pharm 493:285-294 

    상세보기

19. Int J Pharm SP Vyas 296 80 2005 10.1016/j.ijpharm.2005.02.016 Vyas SP, Singh RP, Jain S, Mishra V, Mahor S, Singh P, Gupta PN, Rawat A, Dubey P (2005) Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm 296:80-86 

    상세보기

20. Mol Pharm Z Wang 9 9 2646 2012 10.1021/mp3002107 Wang Z, Yu Y, Ma J, Zhang H, Wang X, Wang J, Zhang X, Zhang Q (2012) LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics. Mol Pharm 9(9):2646-2657 

    상세보기